Employer-Sponsored Health Insurance


KFF has conducted this annual survey of private and non-federal public employers with three or more workers since 1999. The survey tracks trends in employer health insurance coverage, the cost of that coverage, and other topical health insurance issues. Findings are based on a nationally representative survey of public and private employers with three or more employees, including those who respond to the full survey and those who indicate only whether or not they provide health coverage. Browse the reports


Filter

191 - 200 of 444 Results

  • Why Some Employers are Turning to Progressive Health Benefits

    From Drew Altman

    In this Axios column, Drew Altman examines the status of progressive health benefits (health benefits linked to wage levels) and their pros and cons at a time when employee health costs are rising and wages are flat.

  • Analysis: Cost of Treating Opioid Addiction Rose Rapidly for Large Employers as the Number of Prescriptions Has Declined

    News Release

    A new Kaiser Family Foundation analysis finds that while the use of prescription opioids among people with employer-based health coverage has declined to its lowest levels in over a decade, the cost of treating addiction and overdoses has increased sharply. The annual cost of treating opioid addiction and overdose – stemming from both prescription and illicit use -- has increased by more than eight-fold since 2004, from $0.3 billion dollars to $2.6 billion in 2016.…

  • State and Federal Contraceptive Coverage Requirements: Implications for Women and Employers

    Issue Brief

    Before the ACA was passed, many states had enacted contraceptive equity laws that required plans to treat contraceptives in the same way they covered other services. In addition, since the ACA was passed, a number of states have enacted laws that basically codify in state legislation the ACA benefit rules. This issue brief provides an update on the status of the continuing litigation on the federal contraceptive requirement and explains the interplay between the federal…

  • Don’t Overhype the New Health Care Venture

    From Drew Altman

    In an Axios column, Drew Altman dissects the many dimensions of the health cost problem and discusses why the Bezos-Buffett-Dimon initiative is unlikely to have much impact on the larger health cost problems the public and policymakers care about most.

  • The Biggest Health Issue We Aren’t Debating

    From Drew Altman

    In an Axios column, Drew Altman raises a health care issue that isn’t being debated, a large share of the public don’t have the assets to cover the cost sharing in their health plan if they get sick.

  • One Big Thing People Don’t Know About Single Payer

    From Drew Altman

    In this Axios column, Drew Altman discusses a challenge for single payer which has not received much attention – a large share of the American people do not think they would have to change their current health insurance arrangements if there were a Medicare-for-all style single payer plan.

  • Kaiser Health Tracking Poll – October 2017: Experiences of the Non-Group Marketplace Enrollees

    Feature

    The start of the open enrollment period for non-group insurance in 2018 is less than one month away, and the majority of individuals who are targets for enrollment – those who currently purchase their own insurance and those who are uninsured – are unaware of the key dates of the next open enrollment period. This report, focusing on enrollees in the non-group market, compares the experiences of individuals who purchase their own insurance through an…